GLP-1 receptor agonist
Type: Concept
As of November 2026, GLP-1 receptor agonist has been mentioned in one podcast episode on The Diary Of A CEO (Mar 2026). GLP-1 receptor agonists are mentioned as a method to aid in weight loss and reduce visceral fat.
Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 agonists and GLP-1RAs, are a class of medications that activate the GLP-1 receptor, causing reduced blood sugar, reduced appetite, and reduced energy intake. GLP-1 analogs are molecules that are structurally almost identical to the endogenous GLP-1 hormone. Incretin mimetics are substances that mimic the actions of incretin hormones such as GLP-1 and GIP.
| Mentioned in | 1 episode on 1 podcast (as of November 2026) |
|---|---|
| First heard | Mar 2026 on The Diary Of A CEO |
| Field | Pharmacology |
Who talks about GLP-1 receptor agonist on podcasts?
GLP-1 receptor agonist came up; the most recent mention was Mar 2026 on The Diary Of A CEO.
What is GLP-1 receptor agonist mentioned alongside?
GLP-1 receptor agonist is most often mentioned alongside sulforaphane, phthalates and autism spectrum disorder.
Mentioned together: sulforaphane, phthalates, autism spectrum disorder, BPA, Estrogen, high-intensity interval training (HIIT), menopause, Intermittent Fasting, Visceral Fat, Alzheimer's disease